1.25
price up icon0.81%   0.01
pre-market  시장 영업 전:  1.31   0.06   +4.80%
loading

Immuneering Corp (IMRX) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
5.99%
15.33
16.30 13.93 13.50 14.68
Operating Income/Loss
5.99%
-15.33
-16.30 -13.93 -13.50 -14.68
Income/Loss From Continuing Operations Before Tax
5.14%
-14.31
-15.08 -12.60 -12.19 -13.60
Income/Loss From Continuing Operations After Tax
5.14%
-14.31
-15.08 -12.60 -12.19 -13.60
Net Income/Loss
5.14%
-14.31
-15.08 -12.60 -12.19 -13.60
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10,114%
29.37
0.2876 29.27 28.65 26.44
Diluted Average Shares
10,114%
29.37
0.2876 29.27 28.65 26.44
Basic Earnings Per Share
5.77%
-0.49
-0.52 -0.43 -0.43 -0.51
Diluted Earnings Per Share
5.77%
-0.49
-0.52 -0.43 -0.43 -0.51
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$72.58
price up icon 0.39%
$21.55
price up icon 0.33%
$33.00
price up icon 0.33%
$28.02
price up icon 0.43%
$101.10
price down icon 3.66%
biotechnology ONC
$254.16
price down icon 0.63%
자본화:     |  볼륨(24시간):